Please use this identifier to cite or link to this item:
https://doi.org/10.3389/fphar.2015.00099
Title: | A practical approach to communicating benefit-risk decisions of medicines to stakeholders | Authors: | Leong, J Walker, S Salek, S |
Keywords: | Article benefit risk summary template clinical decision making document examination drug industry drug information human institutional review interpersonal communication legal liability medical documentation methodology professional standards review organization program evaluation retrospective study risk benefit analysis Singapore user manual utilization review |
Issue Date: | 2015 | Citation: | Leong, J, Walker, S, Salek, S (2015). A practical approach to communicating benefit-risk decisions of medicines to stakeholders. Frontiers in Pharmacology 6 (APR) : 99. ScholarBank@NUS Repository. https://doi.org/10.3389/fphar.2015.00099 | Rights: | Attribution 4.0 International | Abstract: | Purpose: The importance of a framework for a systematic structured assessment of the benefits and risks has been established, but in addition, it is necessary that the benefit-risk decisions and the processes to derive those decisions are documented and communicated to various stakeholders for accountability. Hence there is now a need to find appropriate tools to enhance communication between regulators and other stakeholders, in a manner that would uphold transparency, consistency and standards. Methods: A retrospective, non-comparative study was conducted to determine the applicability and practicality of a summary template in documenting benefit-risk assessment and communicating benefit-risk balance and conclusions for reviewers to other stakeholders. The benefit-risk (BR) Summary Template and its User Manual was evaluated by 12 reviewers within a regulatory agency in Singapore, the Health Sciences Authority (HSA). Results: The BR Summary Template was found to be adequate in documenting benefits, risks, relevant summaries and conclusions, while the User Manual was useful in guiding the reviewer in completing the template. The BR Summary Template was also considered a useful tool for communicating benefit-risk decisions to a variety of stakeholders. Conclusions: The use of a template may be of value for the communicating benefit-risk assessment of medicines to stakeholders. © 2015 Leong, Walker and Salek. | Source Title: | Frontiers in Pharmacology | URI: | https://scholarbank.nus.edu.sg/handle/10635/181471 | ISSN: | 16639812 | DOI: | 10.3389/fphar.2015.00099 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3389_fphar_2015_00099.pdf | 1.61 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License